Growth Metrics

Nexalin Technology (NXL) EBIT Margin (2021 - 2026)

Nexalin Technology has reported EBIT Margin over the past 5 years, most recently at 2473.44% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 1305291.0% year-over-year to 2473.44%; the TTM value through Dec 2025 reached 572.19%, up 402394.0%, while the annual FY2025 figure was 572.19%, 402394.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 2473.44% at Nexalin Technology, up from 12924.3% in the prior quarter.
  • Over five years, EBIT Margin peaked at 2473.44% in Q4 2025 and troughed at 12924.3% in Q3 2025.
  • A 5-year average of 4005.52% and a median of 2508.86% in 2023 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: plummeted -996381bps in 2023 and later soared 1305291bps in 2025.
  • Year by year, EBIT Margin stood at 2406.3% in 2021, then rose by 22bps to 1872.83% in 2022, then plummeted by -322bps to 7910.37% in 2023, then plummeted by -34bps to 10579.48% in 2024, then skyrocketed by 123bps to 2473.44% in 2025.
  • Business Quant data shows EBIT Margin for NXL at 2473.44% in Q4 2025, 12924.3% in Q3 2025, and 2296.22% in Q2 2025.